Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 15, Issue 6, Pages 759-774
Publisher
Future Medicine Ltd
Online
2014-06-04
DOI
10.2217/pgs.14.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocular Disease, Knowledge and Technology Applications in Patients With Diabetes
- (2013) Jennifer Threatt et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- ADAMTS7: a promising new therapeutic target in coronary heart disease
- (2013) Riyaz S Patel et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role for Cysteine Protease Cathepsins in Heart Disease
- (2012) Xian Wu Cheng et al. CIRCULATION
- Cardiovascular Disease and Oral Agent Glucose-Lowering Therapies in the Management of Type 2 Diabetes
- (2012) Philip Home Diabetes Technology & Therapeutics
- BMPR1A is a candidate gene for congenital heart defects associated with the recurrent 10q22q23 deletion syndrome
- (2011) Jeroen Breckpot et al. European Journal of Medical Genetics
- Homeodomain Only Protein X is down-regulated in human heart failure
- (2011) Chinmay M. Trivedi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies
- (2011) Muredach P Reilly et al. LANCET
- Cardiomyopathy in α-Kinase 3 (ALPK3)–Deficient Mice
- (2011) I. Van Sligtenhorst et al. VETERINARY PATHOLOGY
- Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
- (2010) E. E. Creemers et al. CARDIOVASCULAR RESEARCH
- Global healthcare expenditure on diabetes for 2010 and 2030
- (2010) Ping Zhang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Rosiglitazone: a European regulatory perspective
- (2010) E. Blind et al. DIABETOLOGIA
- Revisiting the Rosiglitazone Story — Lessons Learned
- (2010) Clifford J. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Cdc42 is an antihypertrophic molecular switch in the mouse heart
- (2009) Marjorie Maillet et al. JOURNAL OF CLINICAL INVESTIGATION
- Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease
- (2009) Emma Robinson et al. PHARMACOLOGY & THERAPEUTICS
- Cardiac fibroblasts: At the heart of myocardial remodeling
- (2009) Karen E. Porter et al. PHARMACOLOGY & THERAPEUTICS
- Molecular evolution of the junctophilin gene family
- (2009) Alejandro Garbino et al. PHYSIOLOGICAL GENOMICS
- Variant near ADAMTS9 Known to Associate with Type 2 Diabetes Is Related to Insulin Resistance in Offspring of Type 2 Diabetes Patients—EUGENE2 Study
- (2009) Trine Welløv Boesgaard et al. PLoS One
- SeqMap: mapping massive amount of oligonucleotides to the genome
- (2008) H. Jiang et al. BIOINFORMATICS
- Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure
- (2008) Ayman El-Kadi et al. CURRENT DRUG METABOLISM
- Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
- (2008) Helene Von Bibra et al. Diabetes & Vascular Disease Research
- Analysis of Endocrine Disruption in Southern California Coastal Fish Using an Aquatic Multispecies Microarray
- (2008) Michael E. Baker et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- The cardiovascular safety of rosiglitazone
- (2008) Ramzi A Ajjan et al. Expert Opinion On Drug Safety
- Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
- (2008) Kitchener D. Wilson et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now